Status:
COMPLETED
Efficacy and Safety Study on Nasogastric (NG) Tube in Patients With Upper Gastrointestinal Bleed
Lead Sponsor:
University of Texas Southwestern Medical Center
Conditions:
Gastrointestinal Hemorrhage
Liver Cirrhosis
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Upper gastrointestinal tract hemorrhage (UGIH) remains a major cause of morbidity and mortality . Nasogastric aspiration (NGA) is routinely performed in patients with UGIH to obtain important clinical...
Eligibility Criteria
Inclusion
- Patients older then 21 years-old presenting with actual or reported: Hematemesis, Melena, or Hematemesis and Melena
Exclusion
- Refusal to participate
- Severe comorbid conditions making EGD hazardous for the patient, such as myocardial infarction \< 3 months with the exception if the myocardial infarction was caused by the UGIH, hemorrhagic or ischemic stroke \< 3 months, decompensated congestive heart failure, severe respiratory failure unless the patient is already intubated
- Survival expected to be less than 72h as judged by treating clinician
- Prisoners
- Patient with severe mental illness precluding the ability to obtain informed consent
- Ongoing anticoagulation which can not be reversed secondary to patient safety
- Strongly suspected gastrointestinal perforation
- Recent endoscopy (less than 30 days)
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
282 Patients enrolled
Trial Details
Trial ID
NCT00689754
Start Date
January 1 2008
End Date
August 1 2011
Last Update
November 18 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Parkland Memorial Hospital
Dallas, Texas, United States, 75235